Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

ZOETIS INC (ZTS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ZOETIS INC
07/19 ZOETIS : Buy Rating Reconfirmed Today By Deutsche Bank; The TP is Set to $65
07/12 GREAT LEADERSHIP DELIVERS GREAT RESU : An Editorial by Juan Ramón Alaix
07/12 ZOETIS : Joins Bac Vactory Collaboration to Develop Vaccines Against Diseases Ca..
07/04 ZOETIS : Nexvet Biopharma plc ("Nexvet") Supplement Announcement
06/30 ZOETIS : to Host Webcast and Conference Call on Second Quarter 2017 Financial Re..
06/17 ZOETIS : Stake Has Increased by Dsm Capital Partners Llc
06/16 ZOETIS : Announcement Relating to Dispatch of Rule 15 Letter
06/15 ZOETIS : Keybank National Association OH Sells 5,322 Shares of Zoetis Inc. (ZTS)
06/01 ZOETIS : to Participate in the William Blair Growth Stock Conference
05/25 ZOETIS : to Participate in the Stifel 2017 Dental and Veterinary Conference
05/18 ZOETIS : Named One of America’s Best Midsize Employers
05/13 ZOETIS : Animal health company Zoetis to spend $64.5M to expand manufacturing
05/11 ZOETIS INC. (NYSE : ZTS) Files An 8-K Submission of Matters to a Vote of Securit..
05/11 ZOETIS : Declares Third Quarter 2017 Dividend
05/11 ZOETIS : Holds Annual Meeting of Shareholders
More most relevant news
All news about ZOETIS INC
07/19 ZOETIS : Buy Rating Reconfirmed Today By Deutsche Bank; The TP is Set to $65
07/12 GREAT LEADERSHIP DELIVERS GREAT RESU : An Editorial by Juan Ramón Alaix
07/12 ZOETIS : Joins Bac Vactory Collaboration to Develop Vaccines Against Diseases Ca..
07/04 ZOETIS : Nexvet Biopharma plc ("Nexvet") Supplement Announcement
06/30 ZOETIS : to Host Webcast and Conference Call on Second Quarter 2017 Financial Re..
06/17 ZOETIS : Stake Has Increased by Dsm Capital Partners Llc
06/16 ZOETIS : Announcement Relating to Dispatch of Rule 15 Letter
06/15 ZOETIS : Keybank National Association OH Sells 5,322 Shares of Zoetis Inc. (ZTS)
06/09 ZOETIS : to Participate in the William Blair Growth Stock Conference
06/01 ZOETIS : New Findings on Veterinary Parasitology from Zoetis Inc. Summarized (Ef..
More news
Sector news : Veterinary Drugs
05:30pDJSamsung Releases Arthritis Drug in First Foray Into U.S. Pharmaceuticals
03:26pDJBAYER : 2Q 2017 -- Forecast
03:16pDJCorrection to Samsung Drug Story
02:37pDJSamsung Releases Lower-Cost Alternative to Johnson & Johnson's Drug Remicade
07/21 FTSE, sheltered from euro strength, has best week since May
07/21DJGLAXOSMITHKLINE : FDA Approves Injectable Form Of Glaxo's Benlysta
More sector news : Veterinary Drugs
News from SeekingAlpha
07/11 KINDRED BIOSCIENCES : Up 100% YTD With Even Greater Potential In H2
06/23 Buy Hasbro At $110 - Cramer's Lightning Round (6/22/17)
06/16 Valeant viewed brightly by Cantor, as specialty pharmas move past old model
06/16 Premarket analyst action - healthcare
06/13 Premarket analyst action - healthcare
06/12 ARATANA : Why You Might Want To Grab A Few Shares In This Rapidly Expanding Comp..
Latest Tweets
07/21Zoetis's buy rating reiterated at Stifel Nicolaus. $65.00 PT.  
07/21Zoetis Inc. $ZTS Given a $70.00 Price Target by Cowen and Company Analysts  
07/19Zoetis Inc. $ZTS Position Reduced by Patten & Patten Inc. TN  
07/19Zoetis Inc. $ZTS Position Increased by Louisiana State Employees Retirement S.. 
07/19Zoetis Inc. $ZTS Given a $70.00 Price Target by Cowen and Company Analysts  
More tweets
Qtime:73
Financials ($)
Sales 2017 5 193 M
EBIT 2017 1 788 M
Net income 2017 1 085 M
Debt 2017 3 487 M
Yield 2017 0,67%
P/E ratio 2017 29,20
P/E ratio 2018 24,55
EV / Sales 2017 6,64x
EV / Sales 2018 6,20x
Capitalization 30 999 M
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 66,2 $
Spread / Average Target 4,8%
EPS Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC17.99%30 999
JINYU BIO-TECHNOLOGY CO LTD49.34%3 196
DECHRA PHARMACEUTICALS PLC29.52%2 109
VIRBAC-7.78%1 521
PHIBRO ANIMAL HEALTH CORP30.72%1 518
SHANGHAI HILE BIO-TECHNOLOGY CO LTD-28.62%1 211